Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SUCCINYLCHOLINE Cause Therapy non-responder? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Therapy non-responder have been filed in association with SUCCINYLCHOLINE (Succinylcholine Chloride). This represents 0.3% of all adverse event reports for SUCCINYLCHOLINE.

7
Reports of Therapy non-responder with SUCCINYLCHOLINE
0.3%
of all SUCCINYLCHOLINE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Therapy non-responder From SUCCINYLCHOLINE?

Of the 7 reports, 2 (28.6%) required hospitalization, and 1 (14.3%) were considered life-threatening.

Is Therapy non-responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SUCCINYLCHOLINE. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does SUCCINYLCHOLINE Cause?

Drug ineffective (310) Anaphylactic shock (287) Hyperthermia malignant (276) Hypotension (190) Foetal exposure during pregnancy (152) Maternal exposure during pregnancy (120) Cardiac arrest (119) Anaphylactic reaction (109) Rhabdomyolysis (102) Exposure during pregnancy (95)

What Other Drugs Cause Therapy non-responder?

ETANERCEPT (3,472) APREMILAST (3,360) METHOTREXATE (2,965) RITUXIMAB (2,731) ADALIMUMAB (2,595) PREDNISONE (2,563) TREPROSTINIL (2,289) INFLIXIMAB (2,122) TOCILIZUMAB (1,775) HYDROXYCHLOROQUINE (1,699)

Which SUCCINYLCHOLINE Alternatives Have Lower Therapy non-responder Risk?

SUCCINYLCHOLINE vs SUCRALFATE SUCCINYLCHOLINE vs SUCROFERRIC OXYHYDROXIDE SUCCINYLCHOLINE vs SUCROSE SUCCINYLCHOLINE vs SUFENTANIL SUCCINYLCHOLINE vs SUGAMMADEX

Related Pages

SUCCINYLCHOLINE Full Profile All Therapy non-responder Reports All Drugs Causing Therapy non-responder SUCCINYLCHOLINE Demographics